Biocartis presents the successful use of Idylla for the detection of the BRAF mutation status in tumour samples

Biocartis presents the successful use of Idylla for the detection of the BRAF mutation status in tumour samples

Biocartis introduces IdyllaTM, the brand name for its innovative and high-quality diagnostic platform (previously codenamed Apollo). IdyllaTM is designed to carry out fast and accurate analysis of a broad range of clinical samples. The platform retains the sensitivity of existing technologies but overcomes, amongst others, the current time-consuming testing process of tumour samples.

More

Leave a reply